X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

Virtually everyone who follows government and politics is familiar with new House Speaker Nancy Pelosi, D-Calif. Many know that one of her priorities early in the 110th Congress was passing legislation that affects the government’s ability to negotiate prescription drug prices, and on Jan. 12, the House passed such a bill. Far fewer of us, however, are familiar with Steve Berman of Seattle-based Hagens Berman Sobol Shapiro. But litigation initiated by Berman’s firm in federal court in Massachusetts may play a greater role in establishing drug prices than any law the new Congress may ultimately enact.

If prices for prescription medicines are to be dictated through private litigation rather than public processes, our system of constitutional government, in which legislators and executives accountable to the public write laws and judges apply those laws to resolve disputes, will suffer badly. Such “regulation through litigation” is undemocratic; it disadvantages individuals and organizations not party to the litigation; and it creates incentives that have less to do with sound policy outcomes and more to do with the pursuit of high legal fees.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Advance® Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]

 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2021 ALM Media Properties, LLC. All Rights Reserved.